• Posted: August 7, 2017 The MMRF Mourns the Loss of Honorary Board Member and Friend, Don Baylor

    READ MORE
  • Posted: June 21, 2017 2017 Advances in Minimal Residual Disease (MRD) Testing in Multiple Myeloma

    READ MORE
  • Posted: June 7, 2017 ASCO 2017 - Monday Blog

    Today at ASCO, there were several sessions reporting new and interesting information for patients.

    READ MORE
  • Posted: June 5, 2017 ASCO 2017 - Sunday Blog

    READ MORE
  • Posted: May 1, 2017 MMRF Convenes Top Minds in Cancer at Immune Therapy Summit in Boston

    Held in Boston, Massachusetts, the MMRF Accelerating the Next Generation of Immune Treatments in Cancer Summit convened top experts from oncology, academia,...

    READ MORE
  • Posted: April 25, 2017 Proteasome inhibitors

    Myeloma cells generate lots of additional proteins, like M proteins, that aren’t useful to the body. One way to target myeloma cells is to use these extra,...

    READ MORE
  • Posted: April 25, 2017 Finding the right specialist and treatment center

    Selecting a specialist and a treatment center are among the most important decisions you have to make as an individual with multiple myeloma (MM). Various...

    READ MORE
  • Posted: April 3, 2017 The MMRF Mourns the Loss of Board Member and Friend, Gene Grisanti

    READ MORE
  • Posted: March 21, 2017 Early treatment of smoldering multiple myeloma

    Smoldering multiple myeloma (SMM) is a precursor condition associated with multiple myeloma. Because patients with SMM lack symptoms, the condition is...

    READ MORE
  • Posted: March 17, 2017 The myeloma care team: a who’s who of healthcare professionals

    As an individual with multiple myeloma, you may be interacting with various members of your healthcare team. Understanding who’s who can help you prepare...

    READ MORE

Page 2/15